These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 21816754)

  • 1. Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻ secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin.
    Reif GA; Yamaguchi T; Nivens E; Fujiki H; Pinto CS; Wallace DP
    Am J Physiol Renal Physiol; 2011 Nov; 301(5):F1005-13. PubMed ID: 21816754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells.
    Pinto CS; Reif GA; Nivens E; White C; Wallace DP
    Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1412-24. PubMed ID: 22952279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
    Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
    Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
    Sundar SV; Zhou JX; Magenheimer BS; Reif GA; Wallace DP; Georg GI; Jakkaraj SR; Tash JS; Yu ASL; Li X; Calvet JP
    Am J Physiol Renal Physiol; 2022 Oct; 323(4):F492-F506. PubMed ID: 35979967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tolvaptan, a vasopressin V
    Yamada Y; Fujiki H; Mizuguchi H; Takeshita Y; Hattori K; Ohmoto K; Aihara M; Nagano K; Isakari Y; Yamamoto M; Yamamura Y
    Nihon Yakurigaku Zasshi; 2022; 157(4):254-260. PubMed ID: 35781456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.
    Pinto CS; Raman A; Reif GA; Magenheimer BS; White C; Calvet JP; Wallace DP
    J Am Soc Nephrol; 2016 Apr; 27(4):1124-34. PubMed ID: 26289612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylurea-sensitive K(+) transport is involved in Cl(-) secretion and cyst trowth by cultured ADPKD cells.
    Sullivan LP; Wallace DP; Gover T; Welling PA; Yamaguchi T; Maser R; Eppler JW; Grantham JJ
    J Am Soc Nephrol; 2002 Nov; 13(11):2619-27. PubMed ID: 12397031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the role of vasopressin antagonism in polycystic kidney diseases: From adults to children?
    Janssens P; Weydert C; De Rechter S; Wissing KM; Liebau MC; Mekahli D
    Pediatr Nephrol; 2018 Mar; 33(3):395-408. PubMed ID: 28455745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways.
    Jansson K; Nguyen AN; Magenheimer BS; Reif GA; Aramadhaka LR; Bello-Reuss E; Wallace DP; Calvet JP; Blanco G
    Am J Physiol Renal Physiol; 2012 Oct; 303(7):F982-90. PubMed ID: 22859406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.
    Jansson K; Venugopal J; Sánchez G; Magenheimer BS; Reif GA; Wallace DP; Calvet JP; Blanco G
    J Membr Biol; 2015 Dec; 248(6):1145-57. PubMed ID: 26289599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)].
    Miranda N; Miranda F; Rinaldi L; Stratigis S; Capasso G
    G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells.
    Yamaguchi T; Reif GA; Calvet JP; Wallace DP
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F944-51. PubMed ID: 20810616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloride and fluid secretion by cultured human polycystic kidney cells.
    Wallace DP; Grantham JJ; Sullivan LP
    Kidney Int; 1996 Oct; 50(4):1327-36. PubMed ID: 8887295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.
    Yamaguchi T; Pelling JC; Ramaswamy NT; Eppler JW; Wallace DP; Nagao S; Rome LA; Sullivan LP; Grantham JJ
    Kidney Int; 2000 Apr; 57(4):1460-71. PubMed ID: 10760082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease.
    Belibi FA; Wallace DP; Yamaguchi T; Christensen M; Reif G; Grantham JJ
    J Am Soc Nephrol; 2002 Nov; 13(11):2723-9. PubMed ID: 12397042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney disease.
    Albaqumi M; Srivastava S; Li Z; Zhdnova O; Wulff H; Itani O; Wallace DP; Skolnik EY
    Kidney Int; 2008 Sep; 74(6):740-9. PubMed ID: 18547995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro.
    Davidow CJ; Maser RL; Rome LA; Calvet JP; Grantham JJ
    Kidney Int; 1996 Jul; 50(1):208-18. PubMed ID: 8807590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.
    Torres VE; Meijer E; Bae KT; Chapman AB; Devuyst O; Gansevoort RT; Grantham JJ; Higashihara E; Perrone RD; Krasa HB; Ouyang JJ; Czerwiec FS
    Am J Kidney Dis; 2011 May; 57(5):692-9. PubMed ID: 21333426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tolvaptan on renal handling of water and sodium, GFR and central hemodynamics in autosomal dominant polycystic kidney disease during inhibition of the nitric oxide system: a randomized, placebo-controlled, double blind, crossover study.
    Al Therwani S; Malmberg MES; Rosenbaek JB; Bech JN; Pedersen EB
    BMC Nephrol; 2017 Aug; 18(1):268. PubMed ID: 28810844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors.
    Li H; Findlay IA; Sheppard DN
    Kidney Int; 2004 Nov; 66(5):1926-38. PubMed ID: 15496164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.